Your browser doesn't support javascript.
loading
Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?
Lambert, Elisabeth A; Straznicky, Nora E; Dixon, John B; Lambert, Gavin W.
Affiliation
  • Lambert EA; Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Physiology, Monash University, Clayton, Australia; elisabeth.lambert@bakeridi.edu.au.
  • Straznicky NE; Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;
  • Dixon JB; Clinical Obesity Research Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia; and.
  • Lambert GW; Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
Am J Physiol Heart Circ Physiol ; 309(2): H244-58, 2015 Jul 15.
Article in En | MEDLINE | ID: mdl-25980020
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sympathetic Nervous System / Cardiovascular Diseases / Intra-Abdominal Fat / Obesity Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Am J Physiol Heart Circ Physiol Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sympathetic Nervous System / Cardiovascular Diseases / Intra-Abdominal Fat / Obesity Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Am J Physiol Heart Circ Physiol Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2015 Document type: Article